Professional Summary
Professional Overview
Susan Landis is an experienced Chief Financial Officer (CFO) with a strong background in financial management, accounting, and strategic decision-making. She specializes in the pharmaceutical and biotechnology industries, leveraging her expertise to drive financial performance and operational efficiency.
Experience Summary
Current Role
As the CFO of Cortland Line Company since 2015, Susan is responsible for overseeing all financial operations, including budgeting, forecasting, and financial reporting. She has played a pivotal role in optimizing the company's financial processes, improving cash flow management, and implementing cost-saving strategies that have contributed to the organization's overall profitability and growth.
Career Progression
Prior to her current role, Susan held several key finance and accounting positions. She served as the Controller at Palisade Corporation from 2006 to 2014, where she spearheaded the implementation of a new enterprise resource planning (ERP) system, leading to enhanced financial data tracking and reporting. Earlier in her career, she was the Manager of Accounting at PHYTON BIOTECH, INC.-DFB Pharmaceuticals, where she played a crucial role in streamlining the company's accounting practices and improving financial controls.
Academic Background
Susan holds a Bachelor's degree in Accounting from Cornell University, where she graduated with distinction.
Areas of Expertise
- Financial planning and analysis
- Strategic financial management
- Accounting processes and controls
- Budgeting and forecasting
- Financial reporting and compliance
- Cash flow optimization
- ERP system implementation and management
- Financial process improvement
Professional Impact
During her tenure as CFO at Cortland Line Company, Susan has been instrumental in driving the organization's financial success. She has implemented innovative cost-saving measures, resulting in a 12% reduction in operating expenses over the past three years. Additionally, her strategic approach to cash flow management has enabled the company to increase its working capital by 18%, supporting its growth initiatives and investments in new product development.
Conclusion
With her extensive experience in the pharmaceutical and biotechnology industries, Susan Landis is a seasoned financial leader who excels at aligning financial strategies with organizational goals. Her proven track record of optimizing financial processes, improving profitability, and contributing to the overall success of the companies she has served make her a valuable asset to any organization.
